← Eichor
Condition: Affective Psychoses Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Affective Psychoses

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
NA · 1 location(s) · The Royal Ottawa Mental Health Centre · NCT05973110Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or B
NA · 2 location(s) · Vestre Viken Hospital Trust · NCT06197048Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Phase 2/Phase 3 · 1 location(s) · Michigan State University · NCT06529029Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
Phase 4 · 1 location(s) · University of Massachusetts, Worcester · NCT06174116Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project
Phase N/A · 1 location(s) · Bjorn H. Ebdrup · NCT06743711Skills for Wellness
NA · 2 location(s) · Nova Scotia Health Authority · NCT01980147Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
NA · 1 location(s) · Nathan Kline Institute for Psychiatric Research · NCT07469384Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Phase 1/Phase 2 · 1 location(s) · Vishwajit Nimgaonkar, MD PhD · NCT03794076SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study
NA · 1 location(s) · King's College London · NCT06568081MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI
NA · 1 location(s) · VA Office of Research and Development · NCT06138054CBT-CP for Veterans With SMI
NA · 1 location(s) · VA Office of Research and Development · NCT06758414Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Anal
NA · 1 location(s) · Shanghai Mental Health Center · NCT06904079Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schi
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT04278339iTBS to Enhance Social Cognition in People With Psychosis
NA · 1 location(s) · Northwell Health · NCT06118268Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate
Phase 2 · 1 location(s) · National Cheng-Kung University Hospital · NCT06340789Acetazolamide for Treatment Resistant Schizophrenia
Phase 1/Phase 2 · 2 location(s) · Vishwajit Nimgaonkar, MD PhD · NCT04887792TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis
Phase N/A · 2 location(s) · Mental Health Centre Copenhagen, Bispebjerg and Frederiksber · NCT07716969Visual Perception in Schizophrenia
NA · 1 location(s) · University of Rochester · NCT06911931Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Phase 4 · 1 location(s) · Mayo Clinic · NCT07213466Exploring the Feasibility of Transcranial Ultrasound Stimulation in the Treatment of Schizophrenia
NA · 1 location(s) · Far Eastern Memorial Hospital · NCT07621549Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
NA · 1 location(s) · Mclean Hospital · NCT05343598Bazedoxifene -Treatment for Women With Schizophrenia
Phase 4 · 1 location(s) · The Alfred · NCT04113993Cognitive Training for Emotion Regulation in Psychotic Disorders
NA · 1 location(s) · University of Georgia · NCT04414215A Study on the Preference of Risperidone Dosage Forms
Phase N/A · 1 location(s) · Shanghai Mental Health Center · NCT06657430Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients
Phase N/A · 1 location(s) · University of Edinburgh · NCT07398365Ocrelizumab for Psychosis by Autoimmunity
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT03971487Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Phase 4 · 1 location(s) · University of North Carolina, Chapel Hill · NCT05282277SEEG-Guided DBS for Schizophrenia
NA · 1 location(s) · Ruijin Hospital · NCT07671261
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.